Key result
Cardiorenal syndrome affects up to ~90% of heart failure patients, driving increased mortality.
Why the study?
Despite recognition of cardiorenal syndrome and its five types, many aspects of the problem remain unclear.
Cardiorenal syndrome is a highly prevalent complication across the spectrum of acute and chronic heart failure that portends a poor clinical prognosis.
High prevalence warrants renal monitoring in heart failure; leaves open optimal management strategies for prospective trials.
The combination of heart failure and renal failure is called cardiorenal syndrome. It is a stage of the cardiorenal continuum and, possibly, a small link of the cardiorenal-cerebral-metabolic axis. Despite the fact that the phrase “cardiorenal syndrome” and its five types have become a part of the medical lexicon, many aspects of this problem are still not clear. Cardiorenal syndrome can be diagnosed in 32-90.3% of patients with heart failure. Cardiorenal syndrome type 1 or 2 develops in most cases of heart failure: cardiorenal syndrome presents with the development ofchronic kidney disease in patients with chronic heart failure and acute kidney injury in patients with acute heart failure. Impaired renal function has an unfavorable prognostic value. It leads to an increase in the mortality of patients with heart failure. It is necessary to timely diagnose the presence of cardiorenal syndrome and take into account its presence when managing patients with heart failure. Further researches are needed on ways toprevent the development and prevent the progression of kidney damage in patients with heart failure, to which the efforts of the multidisciplinary team should be directed. The first part of this review examines the currently definition, classification, pathogenesis, epidemiology and prognosis of cardiorenal syndrome in patients with heart failure.
No takes yet. Share an insight, caveat, or question.
Резник et al. (2019) conducted a review in Cardiorenal syndrome in heart failure. Cardiorenal syndrome was evaluated. Cardiorenal syndrome is diagnosed in 32-90.3% of patients with heart failure, leading to unfavorable prognosis and increased mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: